PTC Therapeutics SG&A Expense (Quarterly) Insights

PTC Therapeutics Inc (PTCT)

32.30 +1.24 (+3.99%) USD | NASDAQ | May 10, 16:00

32.30 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2012. Upgrade now.

Date	Value
March 31, 2024	73.27M
December 31, 2023	76.29M
September 30, 2023	80.89M
June 30, 2023	88.45M
March 31, 2023	86.91M
December 31, 2022	92.72M
September 30, 2022	80.12M
June 30, 2022	79.89M
March 31, 2022	73.27M
December 31, 2021	86.55M
September 30, 2021	69.25M
June 30, 2021	68.88M
March 31, 2021	61.10M
December 31, 2020	75.46M
September 30, 2020	57.84M
June 30, 2020	53.66M
March 31, 2020	58.21M
December 31, 2019	63.50M
September 30, 2019	49.28M
June 30, 2019	49.22M
March 31, 2019	40.54M
December 31, 2018	48.67M
September 30, 2018	38.37M
June 30, 2018	33.54M
March 31, 2018	32.97M

Date	Value
December 31, 2017	35.48M
September 30, 2017	31.42M
June 30, 2017	28.87M
March 31, 2017	25.50M
December 31, 2016	24.17M
September 30, 2016	23.65M
June 30, 2016	23.37M
March 31, 2016	25.94M
December 31, 2015	25.89M
September 30, 2015	21.37M
June 30, 2015	17.21M
March 31, 2015	17.62M
December 31, 2014	18.02M
September 30, 2014	10.53M
June 30, 2014	8.733M
March 31, 2014	7.54M
December 31, 2013	7.484M
September 30, 2013	6.679M
June 30, 2013	6.595M
March 31, 2013	4.461M
December 31, 2012	3.224M
September 30, 2012	3.784M
June 30, 2012	3.164M
March 31, 2012	4.443M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

49.22M

Minimum

Jun 2019

92.72M

Maximum

Dec 2022

71.24M

Average

73.27M

Median

SG&A Expense (Quarterly) Benchmarks